Mayor Lurie's power to fast track S.F. homelessness, drug programs is expiring. What did he do with it?

Changes authorized by San Francisco Mayor Daniel Lurie's ordinance allowed addiction treatment and shelters to open much more ...
InForum

College Insider: Foltz flourishing in first year with Bison men's track

Foltz said he initially planned to go to South Dakota State out of high school, but decided to go to Mankato after he toured ...

UVU announces initiative to help students enter workforce sooner

”We know that every student is unique," said Wendy Simmerman, UVU’s senior director of workforce alignment, in making the ...
WGLT

Rivian's first test R2s come off the line after fast-track expansion in Normal

Rivian's first R2s — test models called manufacturing validation build vehicles — drove off the line earlier this month, with ...

Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program

A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and ...

Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
Aviation Week Network

U.S. Opens Fast-Tracked Path For Hypersonic Mass Production

The Multi-service Advanced Capability Hypersonic Accelerator (MACH-XL) program will select prototypes for air-to-air, air-to-ground, ground-to-ground and ground-to-air missiles that have a path to ...
The Caledonian Record

INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...
BioSpace

INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™

ROCHESTER, Minn.--(BUSINESS WIRE)--INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet ...
Business Insider

Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
BioSpace

Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations

TARA-002 selected for FDA manufacturing development and readiness pilot program NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company ...